Tag: cancer research

March 18, 2019

Pascal Biosciences Partners with Mitacs to Support Innovative Cancer Research at University of British Columbia

Pascal Biosciences (TSXV:PAS) has announced it has entered into a partnership with Mitacs for a multi-year cancer research project at...
February 3, 2019

Checkpoint Inhibitors Driving the Immunotherapy Market

The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
May 9, 2018

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 18, 2018

Biotech Update: Q1 2018 in Review

With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 17, 2018

CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the presentation of...
April 17, 2018

Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA

Dynavax Technologies Corporation (NASDAQ:DVAX) announced data from its ongoing Phase 1b/2 study investigating SD-101, Dynavax’s intratumoral TLR9 agonist, in combination...